Brief: 3D signatures new initiative to distinguish between two forms of lung cancer

Telo Genomics

07/12/2016 12:08

Dec 7 (Reuters) - 3d Signatures Inc  DXD.V  
    * 3D signatures inc - additional studies are being planned 
between iucpq and 3ds, to move 3ds' novel biomarker closer to 
commercialization 
    * 3D signatures inc - 3d signatures molecular imaging 
technology shows potential in improving management of lung 
cancer patients with multiple lesions 
 
Source text for Eikon:  ID:nCCNM2M45  
Further company coverage:  DXD.V  
 
 ((Bangalore.newsroom@thomsonreuters.com;))